Tumor-infiltrating lymphocytes (TILs) therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tumor-infiltrating lymphocytes (TILs) therapy, covering 2024-09-05 to 2024-09-05. Get the full timeline:
Most recent: Clinical Trial Update: "Re-Stimulated" TILs and IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]